FDA Approves Fourth Denosumab Biosimilar ...Middle East

Medscape - News
FDA Approves Fourth Denosumab Biosimilar
Denosumab-bnht is expected to launch in the US in June 2025 per an agreement with the reference product’s manufacturer, Amgen. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Fourth Denosumab Biosimilar )

Also on site :